非诺贝特

OBJECTIVEA method for the determination of dissolution of fenofibrate chewable tablets in vitro was established. 目的:建立非诺贝特咀嚼片体外溶出度试验测定方法。

The risk of a first amputation was 36 percent lower among people taking fenofibrate than those taking the placebo. 初次截肢的风险非诺贝特组较安慰剂组降低了36%25。

Objective: To study the effects of Provastatin with Micronized Fenofibrate on HDL C and LDL C in old patients. 目的:研究普伐他汀和微粒化非诺贝特对老年人高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)的作用。

Fenofibrate significantly reduced CVD events in those with low HDL cholesterol or hypertension. 非诺贝特显著降低HDL胆固醇水平较低患者或高血压患者的CVD事件。

CONCLUSION:micronised fenofibrate is bene ficial on adjusting lipid level and blood viscosity. 结论：微粒化非诺贝特能有效降低高血脂，同时明显改善了病人的高粘血症。